Management of Obstructive Uropathy and Contraindication of Bethanechol

Risks of Bethanechol in Mechanical Obstruction

• Bethanechol can worsen hydronephrosis and precipitate acute kidney injury in patients with pre‑existing mechanical obstruction because it raises intravesical pressure against a fixed outlet. 1

Diagnostic Precautions Before Bethanechol Use

• Imaging (ultrasound or CT) together with post‑void residual measurement must be performed to rule out mechanical obstruction prior to prescribing bethanechol. 1

Urgent Decompression of Acute Obstructive Uropathy

• In patients with obstructive uropathy complicated by sepsis, anuria, or uncontrolled infection, urgent decompression via percutaneous nephrostomy or ureteral stenting is mandatory. 2

Medical Management of Benign Prostatic Obstruction

• Alpha‑1 adrenergic receptor antagonists (alpha‑blockers) are recommended as first‑line therapy for lower urinary tract symptoms caused by benign prostatic obstruction. 5
• 5‑alpha reductase inhibitors are appropriate for men with clinically enlarged prostates and bothersome symptoms. 6

Medical Expulsive Therapy for Ureteric Stones

• Alpha‑blockers combined with NSAIDs constitute medical expulsive therapy for ureteric stones ≤10 mm. 3
• Conservative medical management of ureteric stones should not exceed 4–6 weeks to avoid irreversible kidney damage. 3
• If medical therapy fails, definitive treatment includes ureteroscopy or shock‑wave lithotripsy. 3

Management of Urethral Stricture

• Direct visual internal urethrotomy or urethral dilation is indicated for short strictures (<2 cm), whereas urethroplasty is recommended for longer strictures (≥2 cm). 8

Antimicrobial Prophylaxis in Obstructive Uropathy

• Antimicrobial prophylaxis should be administered based on prior urine‑culture results when managing obstructive uropathy with infection risk. 4